Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the current ratio high or low?
The current ratio of 15.26 is 123% above its 5-year average of 6.85, around the middle of its 5-year range (2.23–20.86).
As of the fiscal period ended Tuesday, June 30, 2026. 17.14% above its 12-month average of 13.02.
Reported quarterly current ratio; no daily interpolation. Q2 FY2026 (2026-06-30): 15.26.
CURRENT RATIO
15.26
CURRENT RATIO AVG TTM
13.02
CURRENT RATIO AVG 3Y
9.15
CURRENT RATIO AVG 5Y
6.85
CURRENT RATIO AVG 10Y
7.88
CURRENT RATIO AVG 15Y
N/A
CURRENT RATIO AVG 20Y
N/A
CURRENT VS TTM AVG
+17.14%
CURRENT VS 3Y AVG
+66.75%
CURRENT VS 5Y AVG
+122.81%
CURRENT VS 10Y AVG
+93.55%
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
3.75
median of 874 covered companies
CURRENT VS SECTOR MEDIAN
+306.85%
vs the sector median at left
Yarrow Bioscience Inc
Market Cap
$174.27M
Current Ratio
15.26
TTM Avg
13.02
3Y Avg
9.15
5Y Avg
6.85
Market Cap
$173.76M
Current Ratio
3.49
TTM Avg
3.52
3Y Avg
4.49
5Y Avg
5.44
Market Cap
$172.42M
Current Ratio
3.52
TTM Avg
3.66
3Y Avg
3.27
5Y Avg
3.06
Market Cap
$171.13M
Current Ratio
12.82
TTM Avg
9.83
3Y Avg
6.43
5Y Avg
5.45
Market Cap
$169.53M
Current Ratio
1.59
TTM Avg
1.58
3Y Avg
1.42
5Y Avg
1.43
Market Cap
$179.26M
Current Ratio
4.98
TTM Avg
16.09
3Y Avg
15.64
5Y Avg
15.37
Market Cap
$179.75M
Current Ratio
11.22
TTM Avg
14.99
3Y Avg
15.44
5Y Avg
13.43
| NAME | MARKET CAP | CURRENT RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Yarrow Bioscience Inc (YARW) | $174.27M | 15.26 | 13.02 | 9.15 | 6.85 |
| ProQR Therapeutics N.V. (PRQR)vs › | $173.76M | 3.49 | 3.52 | 4.49 | 5.44 |
| Organogenesis Holdings Inc. (ORGO)vs › | $172.42M | 3.52 | 3.66 | 3.27 | 3.06 |
| Precision BioSciences, Inc. (DTIL)vs › | $171.13M | 12.82 | 9.83 | 6.43 | 5.45 |
| Journey Medical Corporation (DERM)vs › | $169.53M | 1.59 | 1.58 | 1.42 | 1.43 |
| Oramed Pharmaceuticals Inc. (ORMP)vs › | $179.26M | 4.98 | 16.09 | 15.64 | 15.37 |
| MediWound Ltd. (MDWD)vs › | $168.92M | 2.32 | 2.15 | 3.17 | 2.88 |
| Compass Therapeutics, Inc. (CMPX)vs › | $179.75M | 11.22 | 14.99 | 15.44 | 13.43 |
| Cue Biopharma, Inc. (CUE)vs › | $168.10M | 1.25 | 2.29 | 3.57 | 4.16 |
| Canton Strategic Holdings Inc (CNTN)vs › | $180.47M | 15.70 | 3.42 | 4.67 | 3.16 |
Current Ratio
15.26
Quick Ratio
15.26
Current Ratio = Current Assets / Current Liabilities
The current ratio measures short-term liquidity — a company's ability to cover current liabilities with current assets. Above 1.0 indicates positive working capital.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | CURRENT RATIO |
|---|---|
| 2026-06-30 | 15.26 |
| 2026-03-31 | 20.86 |
| 2025-12-31 | 12.53 |
| 2025-09-30 | 8.87 |
| 2025-06-30 | 7.60 |
| 2025-03-31 | 4.47 |
| 2024-12-31 | 4.35 |
| 2024-09-30 | 5.81 |
| 2024-06-30 | 7.13 |
| 2024-03-31 | 13.02 |
| 2023-12-31 | 12.73 |
| 2023-09-30 | 2.72 |
| 2023-06-30 | 3.60 |
| 2023-03-31 | 4.39 |
| 2022-12-31 | 4.10 |
| 2022-09-30 | 6.44 |
| 2022-06-30 | 7.60 |
| 2022-03-31 | 7.06 |
| 2021-12-31 | 3.43 |
| 2021-09-30 | 3.63 |
| 2021-06-30 | 2.23 |
| 2021-03-31 | 6.64 |
| 2020-12-31 | 4.01 |
| 2020-09-30 | 4.23 |
| 2020-06-30 | 4.92 |
| 2020-03-31 | 1.74 |
| 2019-12-31 | 7.35 |
| 2019-09-30 | 9.88 |
| 2019-06-30 | 9.50 |
| 2019-03-31 | 11.78 |
| 2018-12-31 | 14.62 |
| 2018-09-30 | 19.16 |
| 2018-06-30 | 18.06 |
| 2018-03-31 | 18.85 |
| 2017-12-31 | 8.17 |
| 2017-09-30 | 10.49 |
| 2017-06-30 | 0.00 |
| 2017-03-31 | 0.00 |
| 2016-12-31 | 8.08 |
| 2016-09-30 | 0.00 |
